A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using Different Injection Devices in Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
This study is a randomized, parallel-group, open-label Phase I clinical trial designed to compare the bioavailability and safety of subcutaneous SHR-1819 injection administered via different injection devices in healthy subjects.
Epistemonikos ID: 7faedb92f767a6e08760f32fbeabefe5626fbc4c
First added on: Dec 05, 2025